Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell receptors (TCRs) recognizing rotavirus-derived peptides are specialized protein complexes on the surface of T lymphocytes that play a pivotal role in the adaptive immune response against rotavirus infections (Angel et al., 2007). These receptors identify specific viral protein fragments, such as those from the VP6 inner capsid or NSP4 enterotoxin, which are presented by Major Histocompatibility Complex (MHC) molecules on infected cells (Nielsen et al., 2015). This recognition event triggers T-cell activation, leading to the secretion of antiviral cytokines like interferon-gamma and the direct lysis of infected enterocytes by cytotoxic T cells (Lappalainen et al., 2015). In clinical practice, the activity of these TCRs is primarily modulated through live-attenuated vaccines, which aim to establish a memory T-cell population capable of rapid response upon re-exposure (UniProt Consortium, 2023). Furthermore, the characterization of these specific TCRs is vital for developing adoptive T-cell therapies for immunocompromised individuals who cannot clear the virus naturally. Understanding the structural basis of this interaction also helps in monitoring vaccine-induced immunity and identifying potential cross-reactivity with self-antigens.
The TCR complex recognizes specific rotavirus peptide-MHC complexes, triggering a signaling cascade through the CD3 subunits and ZAP-70 kinase, which leads to T-cell activation, proliferation, and the release of effector molecules like perforin, granzymes, and IFN-gamma (PubMed: 17556589).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor (TCR) recognizing rotavirus-derived peptides presented on MHC molecules (RV-specific TCR).